Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
July 25, 2023Nampula, July 21 , 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) is collaborating with the District Services of Health, Women and Social Action in Mogovolas and the Provincial Services in Nampula, Mozambique, to deliver surgical treatment for hydrocele, one...
Read more
Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery
July 19, 2023Gavi should waive co-financing requirements for countries with fragile health systems or in humanitarian crises.Geneva, 18 July, 2023 — Today, Médecins Sans Frontières/Doctors Without Borders (MSF) again called on Gavi, the Vaccine Alliance to broaden “catch-up” vaccine coverage for unprotected...
Read more
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
July 18, 2023MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...
Read more
Shortening distances: providing healthcare to indigenous communities in Venezuela’s Delta Amacuro state
July 18, 2023Rivers serve as roads and tropical rainforest stretches to the horizon in Delta Amacuro state, a vast area bordering the Atlantic Ocean in northeastern Venezuela. Largely inaccessible, this region is home to a large number of Indigenous communities who face...
Read more
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
July 14, 2023Christophe Perrin, TB advocacy pharmacist, MSF Access Campaign "Today's announcement by the Stop TB Partnership/Global Drug Facility about a deal with pharmaceutical corporation Johnson & Johnson (J&J), for access to affordable generic versions of the lifesaving tuberculosis (TB) drug bedaquiline, offers...
Read more
MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old
June 12, 2023Geneva, 12 June 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) today again urged Gavi, the Vaccine Alliance, to urgently prioritise reaching ‘zero-dose’* and under-immunised children up to age five, by removing barriers to broadening vaccine coverage for unprotected children,...
Read more
Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production
May 11, 2023MSF calls on US based corporations Abbott and BD to ensure adequate supply of CD4 tests and equipment. Geneva, 11 May 2023 – In a new report released today, Médecins Sans Frontières/Doctors Without Borders (MSF) warned that access to point-of-care...
Read more
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
April 27, 2023Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many Geneva, 26 April 2023 – Ahead of Johnson & Johnson’s (J&J) annual shareholders meeting, the international medical humanitarian organisation Médecins...
Read more
MSF fights chronic kidney disease in southern Guatemala
August 11, 2022Three years ago, Salomón discovered he was seriously ill with kidney disease. This happened after he was bitten by a snake in a sugarcane field during the zafra - as the sugarcane harvest period is commonly known - in the...
Read more
MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver
June 7, 2022To effectively increase people’s access to all COVID medical tools, governments must return to TRIPS Waiver proposed over 20 months ago At the World Trade Organization (WTO) General Council Meeting (7 June) and the 12th WTO Ministerial Conference (12 –...
Read more
MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB
May 4, 2022Geneva, 3rd May, 2022 - Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World...
Read more
COVID-19: MSF urges governments to reject the draft COVID-19 text at WTO that would set a negative precedent
April 4, 2022Draft text is NOT the intellectual property Waiver for COVID-19 medical tools people need Geneva – Almost one and a half years since India and South Africa first proposed a landmark intellectual property (IP) Waiver for COVID-19 medical tools at the World Trade...
Read more
